Trump Administration Ending Program Designed To Keep Medicare Premiums Down

By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.

By Joshua P. Cohen, Senior Contributor